Immunogenicity associated with metreleptin treatment in patients with obesity or lipodystrophy

Abstract

Development of in vitro neutralizing activity could be associated with loss of efficacy but has not been consistently associated with adverse clinical consequences. Whether neutralization of endogenous leptin with clinical consequences occurs remains unclear.